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Background: Lack of normal asymmetry in the brain has been reported in patients with schizophrenia. However,
it remains unclearwhether disrupted asymmetry originates from inter-hemispheric functional connectivity (FC)
and/or intra-hemispheric FC in this patient population.
Methods: Forty-four patients with drug-naive, ﬁrst-episode schizophrenia, 42 unaffected siblings, and 44 healthy
controls underwent resting-state functional magnetic resonance imaging (fMRI) scan. The parameter of asym-
metry (PAS) and support vector machine (SVM) were used to analyze the data. Patients were treated with
olanzapine for 8 weeks.
Findings: Compared with healthy controls, patients showed lower PAS scores in the left middle temporal gyrus
(MTG)/inferior temporal gyrus (ITG), left posterior cingulate cortex (PCC)/precuneus and left angular gyrus,
and higher PAS scores in the left precentral gyrus/postcentral gyrus. Unaffected siblings also showed lower
PAS scores in the leftMTG/ITG and left PCC/precuneus relative to healthy controls. Further, SVM analysis showed
that a combination of the PAS scores in these two clusters in patients at baseline was able to predict clinical re-
sponse after 8 weeks of olanzapine treatment with 77.27% sensitivity, 72.73% speciﬁcity, and 75.00% accuracy.
Interpretation: The present study suggests disrupted asymmetry of inter- and intra-hemispheric FC in drug-naive,
ﬁrst-episode schizophrenia; in addition, a reduced asymmetry of inter-hemispheric FC in the left MTG/ITG and
left PCC/precuneusmay serve as an endophenotype for schizophrenia, andmay have clinical utility to predict re-
sponse to olanzapine treatment.
Fund: The National Key R&D Program of China and the National Natural Science Foundation of China.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Functional asymmetry of inter- and intra-hemispheric interaction
exists during the normal development of human brain. For example,
the left hemisphere is more specialized for high spatial frequencies;
whereas the right hemisphere prefers to process low spatial frequencies
[1]. The right hemisphere is also biased towards processing line bisec-
tion [2], line orientation [3], and mental rotation [4] compared to the
left hemisphere. The two hemispheres interact with each other via
callosal ﬁbers [5]. Healthy individuals beneﬁt from such inter-
hemispheric interaction. Having both hemispheres involved in process-
ing tasks is more advantageous than just one hemisphere, especially
when computational complexity increases [6,7]. Further, it has been re-
ported that asymmetry in intra-hemispheric connectivity is associated
with language hemispheric dominance [8].
Even though healthy individuals beneﬁt from normal asymmetry of
inter- and intra-hemispheric interactions for efﬁcient information
processing, such asymmetry is disrupted in schizophrenia. Non-right-
handed individuals are apt to suffer from schizophrenia than
right-handedness [9], which may suggest a failure to develop brain
asymmetry. Crow et al. [10] has reported that structural magnetic reso-
nance imaging (MRI) abnormalities are highly signiﬁcantly selective to
the left hemisphere in schizophrenia. Our group has found reduced
gray matter volume in the left middle temporal gyrus (MTG), but not
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in the rightMTG, in patientswith drugnaive,ﬁrst episode schizophrenia
and their unaffected siblings [11,12]. Disruption of normal asymmetry
in white matter tracts also has been reported in patients with chronic
schizophrenia [13]. In addition, reduced inter-hemispheric connectivity
in patients with schizophrenia has been reported by our group and
others [14,15].
Several important questions are still to be answered with regard to
disrupted asymmetry in the brain in patients with schizophrenia. First,
resting-state functional connectivity (rsFC) strength and independent
component analysis (ICA)were used tomeasure the brain lateralization
in previous studies. Human brain demonstrates inter- and intra-
hemispheric interactions in response to a stimulus. Therefore, the
brain lateralization may be measured by inter- and intra-hemispheric
FCs. It still remains unknown to what extent inter- and/or intra-
hemispheric FC contributes to disrupted asymmetry in the brain in
patients with schizophrenia. Second, it is unclear whether such
disrupted asymmetry represents an endophenotype for schizophrenia.
An endophenotype is state independent and heritable, and segregates
with known illness loci [16]. Endophenotype is often observed in unaf-
fected siblings at an increased rate than in the general population
[11,12]. Third, existing evidence suggests that antipsychotic drugs can
alter rsFC patterns [17–20]; in addition, changes induced by antipsy-
chotic drugs in brain network topology can predict individual treatment
response [21]. However, it is still unknownwhether disrupted asymme-
try in the brain is associated with clinical response to antipsychotic
treatment in patients with schizophrenia.
The present study sought to address these questions. Patients with
drug-naive, ﬁrst-episode schizophrenia, unaffected siblings and healthy
controls were recruited in the study. Resting-state functional MRI (rs-
fMRI) was used to assess voxel-wise inter- and intra-hemispheric FCs.
Inter- and intra-hemispheric FCs were calculated between a given
voxel and other voxels from the opposite hemisphere (inter-hemi-
spheric FCs) and the same hemisphere (intra-hemispheric FCs). Then,
a quantitative parameter of asymmetry (PAS) was calculated to reﬂect
inter- and/or intra-hemispheric asymmetry (PAS = FCinter− FCintra).
This voxel-wise method does not depend on pre-deﬁned regions of
interest (ROIs) in twohemispheres, thereforeminimizingpotential con-
founding effects of structural asymmetry and selection bias caused by
ROIs. Previously, autonomy index (AI), an asymmetry parameter, was
calculated by counting the numbers of voxels with abnormal functional
asymmetry [22]. AI is valuable to quantify functional asymmetry. How-
ever, AI ignores the correlation coefﬁcient of each voxel, which is an im-
portant characteristic of functional asymmetry. Therefore, we proposed
a novel method, PAS, to quantify correlation coefﬁcients of voxels with
functional asymmetry in the present study. Unaffected siblings were re-
cruited to examine whether disrupted asymmetry represent an
endophenotype for schizophrenia. Patients received olanzapine treat-
ment for 8 weeks. Previous univariate analysis could predict clinical re-
sponse at the group level [23], which was of little utility to guide
treatment decision making for individual patients in the clinical setting.
By contrast, pattern classiﬁcation techniques including support vector
machine (SVM) allow prediction at the individual level, which might
be helpful in the clinical setting. Suchmethods have been used to differ-
entiate patients with adolescent-onset schizophrenia and healthy con-
trols [24], and to predict clinical response to electroconvulsive
treatment in patients with major depressive disorder [25]. The purpose
of the present study was to examine whether the baseline PAS scores
can predict individual clinical response to olanzapine treatment at
week 8 using the SVMmethod.
2. Materials and methods
2.1. Subjects
Forty-six patients with drug-naive, ﬁrst-episode schizophrenia and
46 unaffected siblings were recruited from the Mental Health Center,
the Second Afﬁliated Hospital of Guangxi Medical University in China
between June 2013 and July 2014; 46 healthy controls were recruited
from the local community during the same time period. All subjects
were in the age range 18–37 years old and right handed, and had
N6 years of formal education.
Patients were diagnosed with schizophrenia according to the Diag-
nostic and Statistical Manual of Mental Disorders-IV (DSM-IV). They
were never treated with antipsychotic medications or other psychotro-
pic agents. The diagnosis of schizophrenia was further determined by
two research psychiatrists (W.G. and Z.Z.) using the Structural Clinical
Interview for DSM-IV (SCID), patient version [26]. All patients had a
Positive and Negative Syndrome Scale (PANSS) total score of N70 at
baseline. Exclusion criteria included history of nicotine dependence, al-
cohol or other substance dependence, or history of brain injury. A
routine physical examination including review of systems, and routine
laboratory tests including complete blood cell count, a comprehensive
Research in context
Evidence before this study
Wesearched PubMed from the start of the database until June24,
2018, for functional asymmetry of resting-state functional con-
nectivity (rsFC) in patients with schizophrenia, with the search
terms “schizophrenia”, “functional asymmetry”, and “functional
connectivity [Title]”, and “English” [Language]. We found three
published articles before we initiated the study. In these studies,
rsFC strength and independent component analysis (ICA) were
used to measure the brain lateralization. Human brain demon-
strates inter- and intra-hemispheric interactions in response to a
stimulus. Therefore, the brain lateralization may be measured by
inter- and intra-hemispheric FCs. It still remains unknown to
what extent inter- and/or intra-hemispheric FC contribute to
disrupted asymmetry in the brain in patients with schizophrenia.
Added value of this study
Forty-four patients with drug-naive, first-episode schizophrenia,
42 unaffected siblings, and 44 healthy controls were enrolled in
the present study. A quantitative parameter of asymmetry (PAS)
was calculated to reflect inter- and/or intra-hemispheric asymme-
try. Our study demonstrated disrupted asymmetry in patients
with drug naive, first episode schizophrenia and unaffected sib-
lings, which are preferentially within the left hemisphere. A re-
duced asymmetry of inter-hemispheric FC in the left middle
temporal gyrus (MTG)/inferior temporal gyrus (ITG) and left poste-
rior cingulate cortex (PCC)/precuneus may serve as an
endophenotype for schizophrenia, and may have clinical utility to
predict response to olanzapine treatment.
Implications of all the available evidence
First, left-sided abnormal functional asymmetry in the brain in drug
naive, first episode schizophrenia and unaffected siblings demon-
strates that schizophrenia is a brain disorder. Second, reduced
inter-hemispheric FC in the default mode network (DMN) may
bear genetic load and serve as an endophenotype for schizophre-
nia, confirming that schizophrenia is a genetic disorder. Finally,
biomarkers to reflect disrupted functional asymmetry in the
brain, such as a combination of the PAS scores of the left MTG/
ITG and left PCC/precuneus, may have great clinical implications
to help clinicians make individualized treatment decisions for
patients.
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metabolic panel, thyroid function test, urinalysis, electrocardiography,
and chest radiography were performed to exclude any ongoing signiﬁ-
cant medical conditions.
Unaffected siblings and healthy controls were recruited through ad-
vertisement. They went through the same physical examination and
routine laboratory tests to rule out any medical conditions. In addition,
the same research psychiatrists (W.G. and Z.Z.) conducted a structured
clinical interview using the SCID, non-patient version [26] to rule out
any psychiatric conditions. None of them had a history of any psychiat-
ric conditions, nicotine dependence, alcohol or other substance depen-
dence. In addition, those who had a ﬁrst-degree relative diagnosed
with psychiatric disorders were not eligible to be healthy controls.
Patients were treated with olanzapine (10–30 mg/d with a mean
(standard deviation) dose of 18.30 (5.17) mg/d) for 8 weeks. The
PANSS was repeated at week 8.
The study was approved by the ethics committees of the Second Af-
ﬁliated Hospital of Guangxi Medical University. All subjects signed a
written informed consent.
2.2. Image acquisition and preprocessing
Images were obtained using a 3 T MRI scanner (Siemens Verio,
Erlangen, Germany). The images were analyzed using the DPABI soft-
ware [27]. More details about image acquisition and pre-processing
can be found in the Supplementary ﬁles.
2.3. Calculation of the PAS scores
For each subject, correlation coefﬁcients were calculated between a
given voxel and other voxels from the same hemisphere (intra-hemi-
spheric coefﬁcients) or other voxels from the opposite hemisphere
(inter-hemispheric coefﬁcients) by using a voxel-wise whole-brain
analysis. The mean coefﬁcient of this given voxel was termed as the
intra-hemispheric FC or inter-hemispheric FC of this voxel. Because
small correlation coefﬁcients between voxels, which were not signiﬁ-
cantly greater/smaller than zero, might bring in confounding effect on
asymmetry analysis, the PAS calculation was conducted based on a
pre-deﬁned correlation coefﬁcient threshold (r N 0.2) in order to re-
move weak correlations likely due to signal noise [28,29]. To test
whether the choice of correlation coefﬁcient threshold might affect
the ﬁndings, another correlation coefﬁcient threshold (r N 0.25) was
also used according to a previous study [22]. Given the detrimental ef-
fects of negative correlations on test–retest reliability [30] and ambigu-
ous explanation of negative correlations [31–33], the PAS calculation
was restricted to positive correlations only. The mean coefﬁcients
were z transformed as described previously [34]. The PAS values were
calculated using the formula below:
PAS ¼ FCinter−FCintra
FCinter refers to inter-hemispheric FC, and FCintra intra-hemispheric
FC. A positive PAS score means that the asymmetry mainly originates
from inter-hemispheric FC, whereas a negative PAS score means that
the asymmetry primarily results from intra-hemispheric FC. Based on
calculated PAS scores, the PASmapswere generated for further analysis.
2.4. Statistical analyses
Demographic and clinical data were analyzed using Chi-square test
and analysis of variance (ANOVA) as appropriate.
Framewise displacement (FD) was calculated for each subject using
the method described previously [35]. For the PAS maps, analysis of co-
variance (ANCOVA), followed by post hoc t-tests, was used to compare
group differences controlling for the mean FD and age. The signiﬁcance
level was set at p b 0.05 corrected by the Gaussian random ﬁeld (GRF)
theory (voxel signiﬁcance: p b 0.001, cluster signiﬁcance: p b 0.05)
using the REST software [36].
Once abnormal clusters were identiﬁed by group comparisons, the
mean PAS scores were extracted from every cluster in the patient
group. Normality test was conducted to conﬁrm that the data for
mean PAS scores and clinical variables are in normal distribution.
Pearson's correlation analysis was performed within patients to exam-
ine the relationship between the mean PAS scores and clinical variables
including illness duration and the PANSS total scores. The signiﬁcance
level was set at p b 0.05 after the Bonferroni correction.
2.5. SVM analysis
SVM was performed using the LIBSVM software (http://www.csie.
ntu.edu.tw/~cjlin/libsvm/). Patients were divided into two groups
(good response versus poor response) based on the median value of
the reduction ratio (RR) of the PANSS total scores after 8 weeks of
olanzapine treatment. Themedian valuewas used to ensure equal num-
bers of patients between the two groups, which is required for SVM
analysis. The RR was calculated as follows.
RR ¼ PANSStotal 0–PANSStotal 8wð Þ=PANSStotal 0
PANSStotal_0 refers to the PANSS total scores at baseline, whereas
PANSStotal_8w is the PANSS total scores after 8 weeks of treatment.
SVM was used to examine whether the PAS scores at baseline can
predict clinical response to olanzapine treatment at week 8. A “leave-
one-out” procedure was applied to perform SVM.
3. Results
3.1. Characteristics of the subjects
The data of 8 subjects (2 patients, 4 siblings, and 2 controls) were
discarded due to excessive head motion. Therefore, 44 patients, 42 un-
affected siblings, and 44 healthy controls were ﬁnally enrolled. There
were no signiﬁcant differences in age, gender, education level, and the
mean FD across groups (eTable 1). Within patients, the PANSS scores
were signiﬁcantly decreased after 8 weeks of treatment (eTable 2).
As shown in eTable 4, there were no signiﬁcant differences between
the good response group and the poor response group in important de-
mographic and clinical characteristics including age, gender, education
level, illness duration, and dosage of olanzapine (p's N 0.05).
3.2. Group differences in the PAS scores
Spatial maps of the PAS scores for each group were presented in
eFig. 1. Increased PAS scoreswere observed in the lateral prefrontal, lat-
eral parietal, temporal gyri, whereas decreased PAS scores were found
in the visual and sensorimotor regions within patients; our results are
consistent with the ﬁndings from a previous study on hemispheric spe-
cialization in schizophrenia [22].Moreover, the two hemispheres exhib-
ited different patterns of PAS scores in healthy controls, consistent with
the ﬁndings from a previous study in 1000 healthy controls [37].
As shown in eFig. 2, the three groups (patients, unaffected siblings
and healthy controls) differed in the PAS scores in the frontal, temporal,
parietal, and occipital cortices.
Compared with healthy controls, patients at baseline had signiﬁ-
cantly lower PAS scores in the left MTG/inferior temporal gyrus (ITG),
left posterior cingulate cortex (PCC)/precuneus and left angular gyrus,
and signiﬁcantly higher PAS scores in the left precentral grus/
postcentral gyrus (Fig. 1 and Table 1). Unaffected siblings showed sig-
niﬁcantly lower PAS scores in the left MTG/ITG and left PCC/precuneus
relative to healthy controls (Fig. 1 and Table 1). Both patients and unaf-
fected siblings showed lower PAS scores in the left MTG/ITG andleft
PCC/precuneus.
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To test whether the choice of correlation coefﬁcient thresholdmight
affect the ﬁndings, another correlation coefﬁcient threshold of r N 0.25
was used and resulted in similar ﬁndings (eFig. 3 and eTable 3).
A whole-brain voxel-wise statistical comparison of the PAS scores
was conducted between the good response group and the poor
response group based on the median RR. Compared with the poor re-
sponse group, the good response group showed decreased PAS scores
in the left superior parietal lobule and increased PAS scores in the
right precentral gyrus/postcentral gyrus (eTable 5 and eFig. 4). When
themean RRwas used as the cut-off value, similar resultswere obtained
using a whole-brain voxel-wise statistical comparison of the PAS scores
between the good response group (25 patients) and the poor response
group (19 patients) (eTable 5).
3.3. Correlation analysis results
Within patients, no correlations were found between the PAS scores
and the PANSS total scores or the illness duration at baseline.
Fig. 1. Post hoc t-tests across groups. Upper: Group differences in the PAS scores between patients and healthy controls. Bottom: Group differences in the PAS scores between unaffected
siblings and healthy controls. PAS = parameter of asymmetry.
Table 1
Baseline group comparison of the PAS scores using a correlation coefﬁcient threshold
of r N 0.2.
Cluster location Peak (MNI) Number
of voxels
T value
x y z
Patients vs Healthy Controls
Left MTG/ITG −60 −21 −18 64 −4.2399
Left PCC/Precuneus −3 −45 33 170 −4.3947
Left Angular Gyrus −45 −69 33 45 −3.9649
Left Precentral Gyrus/
Postcentral Gyrus
−57 −6 36 70 4.8099
Unaffected Siblings vs
Healthy Controls
Left MTG/ITG −66 −15 −24 21 −4.0102
Left PCC/Precuneus −3 −48 12 22 −4.2168
PAS= parameter of asymmetry; MTG=middle temporal gyrus; ITG= inferior temporal
gyrus; PCC = posterior cingulate cortex.
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3.4. SVM analysis results
Based on themedian of the RR of the PANSS total scores (0.580), pa-
tients were divided into two groups (good response versus poor re-
sponse, 22 patients in each group). Because univariate analysis
showed that both patients and unaffected siblings had reduced PAS
scores in the left MTG/ITG and left PCC/precuneus. SVM analysis was
performed using the baseline PAS scores in these two clusters: the left
MTG/ITG and left PCC/precuneus. The results showed that the PAS
scores from single cluster were not able to predict patients with good
response versus those with poor response after 8 weeks of olanzapine
treatment. The sensitivity, speciﬁcity, and accuracy were 72.73%,
54.55%, and 63.64% respectively in the left MTG/ITG, and 63.64%,
77.27%, and 70.45% respectively in the left PCC/precuneus. However, a
combination of the PAS scores of these two clusters was able to predict
clinical response to olanzapine treatment with 77.27% sensitivity,
72.73% speciﬁcity, and 75.00% accuracy (Fig. 2).
In addition, SVM analysis showed that the PAS scores of the left su-
perior parietal lobule, right precentral gyrus/postcentral gyrus, and the
combination of the two clusters could discriminate the good response
patients from the poor response patients with sensitivities of 77.27%,
90.91%, and 86.36%, speciﬁcities of 77.27%, 86.36%, and 100%, and accu-
racies of 77.27%, 88.64%, and 93.18%, respectively.
4. Discussion
To our knowledge, the present study is the ﬁrst to examine func-
tional asymmetry in ﬁrst-episode, drug-naive schizophrenia and unaf-
fected siblings using a voxel-wise whole-brain analysis. We found that
disrupted asymmetry in schizophrenia is preferentially within the left
hemisphere as reﬂected by reduced inter-hemispheric FC in brain re-
gions of the default-mode network (DMN, including the left MTG/ITG,
left PCC/precuneus, and left angular gyrus) and elevated inter-
hemispheric FC in the sensorimotor region (including the left precentral
gyrus/postcentral gyrus). Patients and unaffected siblings shared re-
duced inter-hemispheric FC in brain regions of the DMN (including
the left MTG/ITG and left PCC/precuneus), which may serve as an
endophenotype for schizophrenia. Furthermore, SVM analysis suggests
that, within patients, a combination of the PAS scores of these two clus-
ters may predict clinical response to olanzapine treatment; the predic-
tion was unlikely confounded by age, gender, education level, illness
duration or daily dosage of olanzapine.
Our group has previously reported abnormal DMN homogeneity in
patients with schizophrenia [38]. In addition, reduced rsFC within the
DMN in patients with schizophrenia has been reported by other groups
[39–41]. However, these studies did not examine whether disrupted FC
in the DMN is primarily contributed by abnormal inter-hemispheric
FC and/or intra-hemispheric FC. In the present study, the whole-brain
FC was divided into inter-hemispheric FC and intra-hemispheric FC. Our
ﬁndings suggest that abnormal FC in brain regions of the DMNmight be
related to reduced inter-hemispheric FC within the left hemisphere.
Interestingly, unaffected siblings also showed reduced inter-
hemispheric FC in the DMN (including the left MTG/ITG and left PCC/
precuneus) in our study. According to the deﬁnition of endophenotype,
reduced inter-hemispheric FC in the left MTG/ITG and left PCC/
precuneus may represent an endophenotype for schizophrenia. Previ-
ously, our group has reported reduced DMN homogeneity in unaffected
siblings of patients with schizophrenia [42]. We also reported reduced
graymatter volume in the leftMTG in both patients and their unaffected
siblings [11,12]. SVM analysis in the present study suggested that a
combination of the PAS scores of these two clusters was able to predict
clinical response to olanzapine treatment with acceptable sensitivity,
speciﬁcity, and accuracy. Genes may play a critical role in the reduced
inter-hemispheric FC in the DMN. For example, additive genetic effects
on the degree of graymatter volume loss in the temporal gyrus over ﬁve
years have been observed in patientswith schizophrenia and unaffected
co-twins [43]. Decreased volume in the MTG has been related to Val al-
lele homozygosity in chronic schizophrenia [44]. Reduced FC in the
DMN has been associated with psychopathology in patients with high
genetic loading for schizophrenia [45]. Therefore, reduced inter-
hemispheric FC in the DMN may bear genetic load and serve as an
endophenotype for schizophrenia.
Decreased activity in the right precentral gyrus has been observed in
schizophrenia [46]; this ﬁnding is consistent with reported functional
deﬁcits in the sensorimotor regions in patients with schizophrenia
[47]. Increased FC is usually considered as compensatory reallocation
or dedifferentiation to functional deﬁcits in the sensorimotor regions
[48–50]. The precentral gyrus is the primary motor cortex; whereas
the primary somatosensory cortex is located in the postcentral gyrus.
Therefore, increased inter-hemispheric FC in the left precentral grus/
postcentral gyrus in the present study may be a compensatory effort
to functional deﬁcits in these regions.
The present study has several novel aspects. First, thewhole brain FC
was divided into inter-hemispheric FC and intra-hemispheric FC, which
are helpful for us to understand whether abnormal FC originates from
Fig. 2. SVManalysis using a combination of the PAS scores in the leftMTG/ITG and left PCC/precuneus. Left: SVMparameters selection result (3D visualization) [Grid SearchMethod]: Best
c=8;Best g=2;Right: thevisualization of classiﬁcation: a combination of thePAS scores of the leftMTG/ITG and left PCC/precuneus. Demension1 represents the PAS scores in the left PCC/
precuneus, whereas dimension2 represents the PAS scores in the left MTG/ITG. PAS= parameter of asymmetry; SVM= support vector machine; MTG=middle temporal gyrus; ITG =
inferior temporal gyrus; PCC = posterior cingulate cortex.
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inter-hemispheric FC and/or intra-hemispheric FC in schizophrenia.
Second, unaffected siblings were included in the present study; this
allowed us to explore potential endophenotypes for schizophrenia.
Third, SVM analysis was used to explore whether asymmetry of inter-
and/or intra-hemispheric FC can serve as biomarkers to predict clinical
response to medication treatment at the individual level; such bio-
markers may have great clinical implications as they can help clinicians
to make individualized treatment decisions for patients [51]. Finally,
drug-naive, ﬁrst-episode patients were recruited in the present study,
eliminating possible confounding effects of prior medication exposure
and the heterogeneity of illness course on brain function [52–54].
In addition to the relatively small study sample size, the study has
some other limitations. First, within patients, the imaging scans were
not repeated after 8weeks of olanzapine treatment. Therefore, themed-
ication treatment effect on functional asymmetry in schizophrenia re-
mains unclear. Second, all patients were treated with olanzapine.
Having patients on the same antipsychotic medication olanzapine was
helpful to minimize the confounding effects caused by the use of differ-
ent antipsychotic medications as they may cause differential effects on
brain function [55,56]; however, this also comprised the generalizability
of the study ﬁndings to patients on antipsychotic medications other
than olanzapine. Third, a correlation coefﬁcient threshold of r N 0.2
was used to calculate the PAS scores. The choice of such a threshold
might affect the ﬁndings. However, another threshold of r N 0.25 was
tested and led to similar ﬁndings. Fourth, although a symmetrical stan-
dard template was used to process the data, the inﬂuence of potential
brain size asymmetry between two hemispheresmay not be eliminated
completely in the calculation of PAS index. Finally, although a number of
strategies were applied to minimize the effect caused by head motion,
such an effect may not be eliminated completely in the present study.
In summary, the present study found reduced inter-hemispheric FC
in the DMN and elevated inter-hemispheric FC in the sensorimotor re-
gions in drug naive, ﬁrst episode schizophrenia, which were preferen-
tially within the left hemisphere. Reduced inter-hemispheric FC in the
DMNmight serve as an endophenotype for schizophrenia and a predic-
tor for clinical response to olanzapine treatment. Future studies to ad-
dress the limitations described above and further examine the clinical
utility of using disrupted asymmetry of inter- and/or intra-
hemispheric FC as a biomarker to predict treatment response in patients
with schizophrenia in the clinical settings are warranted.
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